Skip to main content

Advertisement

SpringerLink
Log in

Association of MAPK and its regulatory miRNAs (603, 4301, 8485, and 4731) with the malignant transformation of oral lichen planus

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Oral lichen planus (OLP) is a potentially malignant oral lesion that may transform into oral squamous cell carcinoma (OSCC). The purpose of this study was to assess the level of expression of MAPK/ERK1/2 gene, and microRNA (miR)-603, 4301, 8485, and 4731 in the MAPK signaling pathway in OLP and OSCC lesions. This case–control study evaluated 26 OSCC, 20 OLP and 20 healthy control tissue specimens. After RNA extraction, the respective miRNA and MAPK/ERK1/2 mRNA levels were assessed by quantitative reverse transcription polymerase chain reaction (RT-PCR). Significant upregulation of MAPK/ERK1/2 gene was noted in the OLP and OSCC specimens compared with healthy controls (p < 0.001). The expression level of miR-4731 was significantly lower in the OLP and OSCC specimens than in the healthy specimens (p < 0.001). The expression of MiR-603 was the lowest in OLP, followed by OSCC and then the control group (p < 0.001). No significant difference was found in miR-4801 levels between OSCC and OLP specimens compared with healthy controls (p = 0.43 and p = 0.86, respectively). In addition, a non-significant decrease in miR-8485 levels was noted in the OSCC and OLP specimens compared with healthy controls (p = 0.98 and p = 0.61, respectively). A significant decrease in level of miR-603 was noted in OLP compared with OSCC group (p < 0.001). The miR-4801 and miR-8485 expression levels were directly correlated with MAPK/ERK1/2 mRNA expression (p = 0.01). Higher expression level of MAPK/ERK1/2, miR-603, miR-4801, and miR-4731, and lower expression level of miR-8485 were correlated with significantly lower overall survival rate in OSCC patients. The increased expression of MAPK/ERK1/2 and decreased expression of miR-603 and miR-4731 are associated with greater risk of OLP malignant transformation and poor histopathological characteristics of OSCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Najafi S, Gholizadeh N, Manifar S, Rajabzadeh S, Kharazi FM (2015) Salivary antioxidant level in oral squamous cell carcinoma. Iran J Blood Cancer 7:57–60

    Google Scholar 

  2. Gholizadeh N, Razavi HE, Haftkhani GJ, Sheykhbahaei N (2019) Predictive factors of survival rate in oral squamous cell carcinoma: a retrospective study in Iran. J Contemp Med Sci 5:101–105

    Google Scholar 

  3. Agha-Hosseini F, Sheykhbahaei N, SadrZadeh-Afshar M (2016) Evaluation of potential risk factors that contribute to malignant transformation of oral lichen planus: a literature review. J Contemp Dent Pract 17:692–701

    Article  Google Scholar 

  4. Rupakar P, Kureshi A, Balar A, Khatri M, Parmar M, Pujara P et al (2016) Estimation of serum B2-microglobulin in oral precancerous lesions and oral squamous cell carcinoma. Natl J Integr Res Med 7:51–55

    Google Scholar 

  5. Aghbari SMH, Abushouk AI, Attia A, Elmaraezy A, Menshawy A, Ahmed MS et al (2017) Malignant transformation of oral lichen planus and oral lichenoid lesions: a meta-analysis of 20095 patient data. Oral Oncol 68:92–102

    Article  CAS  Google Scholar 

  6. Van der Waal I (2014) Oral potentially malignant disorders: is malignant transformation predictable and preventable? Med Oral Patol Oral Cir Bucal 19:e386

    Article  Google Scholar 

  7. Gholizadeh N, Poorfar HK, TaghaviZenouz A, Vatandoost M, Mehdipour M (2015) Comparison of serum autoantibodies to desmogleins I, III in patients with oral lichen planus and healthy controls. Iran J Pathol 10:136

    PubMed  PubMed Central  Google Scholar 

  8. Kumar SS, Zain RB (2018) Aetiology and risk factors for oral cancer–a brief overview. Ann Dent Univ Malaya 11:41–50

    Google Scholar 

  9. Morrison DK (2012) MAP kinase pathways. Cold Spring Harb Perspect Biol 4:a011254

    Article  Google Scholar 

  10. Pierro C, Zhang X, Kankeu C, Trebak M, Bootman MD, Roderick HL (2018) Oncogenic KRAS suppresses store-operated Ca2+ entry and ICRAC through ERK pathway-dependent remodelling of STIM expression in colorectal cancer cell lines. Cell Calcium 72:70–80

    Article  CAS  Google Scholar 

  11. Mayr D, Hirschmann A, Löhrs U, Diebold J (2006) KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants. Gynecol Oncol 103:883–887

    Article  CAS  Google Scholar 

  12. Cui X, Li S, Li T, Pang X, Zhang S, Jin J et al (2014) Significance of elevated ERK expression and its positive correlation with EGFR in Kazakh patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol 7:2382

    PubMed  PubMed Central  Google Scholar 

  13. Regalo G, Resende C, Wen X, Gomes B, Durães C, Seruca R et al (2010) C/EBPα expression is associated with homeostasis of the gastric epithelium and with gastric carcinogenesis. Lab Investig 90:1132

    Article  CAS  Google Scholar 

  14. Pipan V, Zorc M, Kunej T (2015) MicroRNA polymorphisms in cancer: a literature analysis. Cancers (Basel) 7:1806–1814

    Article  CAS  Google Scholar 

  15. Bayraktar R, Pichler M, Kanlikilicer P, Ivan C, Bayraktar E, Kahraman N et al (2017) MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase. Oncotarget 8:11641

    Article  Google Scholar 

  16. Wang J, Luo H, Xiao Y, Wang L (2016) miR-125b inhibits keratinocyte proliferation and promotes keratinocyte apoptosis in oral lichen planus by targeting MMP-2 expression through PI3 K/Akt/mTOR pathway. Biomed Pharmacother 80:373–380

    Article  CAS  Google Scholar 

  17. Aghbari SM, Zayed SO, Shaker OG, Abushouk AI (2019) Evaluating the role of tissue micro RNA-27b as a diagnostic marker for oral lichen planus and possible correlation with CD 8. J Oral Pathol Med 48:68–73

    Article  CAS  Google Scholar 

  18. Aghbari SMH, Abushouk AI, Shakir OG, Zayed SO, Attia A (2018) Correlation between tissue expression of microRNA-137 and CD8 in oral lichen planus. Clin Oral Investig 22:1463–1467

    Article  Google Scholar 

  19. Ahmadi-Motamayel F, Bayat Z, Hajilooi M, Shahryar-Hesami S, Mahdavinezhad A, Samie L et al (2017) Evaluation of the miRNA-146a and miRNA-155 expression levels in patients with oral lichen planus. Iran J Immunol 14:316–324

    PubMed  Google Scholar 

  20. Ghallab NA, Kasem RF, El-Ghani SFA, Shaker OG (2017) Gene expression of miRNA-138 and cyclin D1 in oral lichen planus. Clin Oral Investig 21:2481–2491

    Article  Google Scholar 

  21. Tao Y, Ai R, Hao Y, Jiang L, Dan H, Ji N et al (2019) Role of miR-155 in immune regulation and its relevance in oral lichen planus. Exp Ther Med 17:575–586

    CAS  PubMed  Google Scholar 

  22. Danielsson K, Wahlin Y-B, Gu X, Boldrup L, Nylander K (2012) Altered expression of miR-21, miR-125b, and miR-203 indicates a role for these microRNAs in oral lichen planus. J Oral Pathol Med 41:90–95

    Article  CAS  Google Scholar 

  23. Wang G, Zheng X, Zheng Y, Cao R, Zhang M, Sun Y et al (2019) Construction and analysis of the lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveals functional genes in heart failure. Mol Med Rep 19:994–1003

    CAS  PubMed  Google Scholar 

  24. Cheng J, Chen J, Wang Z, Yu D, Zu Y (2017) The functional role of microRNAs in laryngeal carcinoma. Open Life Sci 12:460–464

    CAS  Google Scholar 

  25. Ayaz L, Görür A, Yaroğlu HY, Özcan C, Tamer L (2013) Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol 139:1499–1506

    Article  CAS  Google Scholar 

  26. Scapoli L, Palmieri A, Muzio LL, Pezzetti F, Rubini C, Girardi A et al (2010) MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int J Immunopathol Pharmacol 23:1229–1234

    Article  CAS  Google Scholar 

  27. Lu J, Zhao J, Liu K, Zhao J, Yang H, Huang Y et al (2010) MAPK/ERK1/2 signaling mediates endothelial-like differentiation of immature DCs in the microenvironment of esophageal squamous cell carcinoma. Cell Mol Life Sci 67:2091–2106

    Article  CAS  Google Scholar 

  28. Sasaki K, Hitora T, Nakamura O, Kono R, Yamamoto T (2011) The role of MAPK pathway in bone and soft tissue tumors. Anticancer Res 31:549–553

    CAS  PubMed  Google Scholar 

  29. Nakanishi H, Taccioli C, Palatini J, Fernandez-Cymering C, Cui R, Kim T et al (2014) Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway. Oncogene 33:702

    Article  CAS  Google Scholar 

  30. Yang X, Wu X (2016) miRNA expression profile of vulvar squamous cell carcinoma and identification of the oncogenic role of miR-590-5p. Oncol Rep 35:398–408

    Article  CAS  Google Scholar 

  31. Ma C, Zhan C, Yuan H, Cui Y, Zhang Z (2016) MicroRNA-603 functions as an oncogene by suppressing BRCC2 protein translation in osteosarcoma. Oncol Rep 35:3257–3264

    Article  CAS  Google Scholar 

  32. Stark MS, Klein K, Weide B, Haydu LE, Pflugfelder A, Tang YH et al (2015) The prognostic and predictive value of melanoma-related microRNAs using tissue and serum: a microRNA expression analysis. EBioMedicine 2:671–680

    Article  Google Scholar 

  33. Stark MS, Tom LN, Boyle GM, Bonazzi VF, Soyer HP, Herington AC et al (2016) The ‘Melanoma-enriched’microRNA miR-4731-5p acts as a tumour suppressor. Oncotarget 7:49677

    Article  Google Scholar 

  34. Hiraki M, Nishimura J, Takahashi H, Wu X, Takahashi Y, Miyo M et al (2015) Concurrent targeting of KRAS and AKT by MiR-4689 is a novel treatment against mutant KRAS colorectal cancer. Mol Ther-Nucleic Acids 4:e231

    Article  CAS  Google Scholar 

  35. Fan Z, Chen X, Chen R (2014) Transcriptome-wide analysis of TDP-43 binding small RNAs identifies miR-NID1 (miR-8485), a novel miRNA that represses NRXN1 expression. Genomics 103:76–82

    Article  CAS  Google Scholar 

  36. Kattimani Y, Veerappa AM (2018) Dysregulation of NRXN1 by mutant MIR8485 leads to calcium overload in pre-synapses inducing neurodegeneration in Multiple sclerosis. Mult Scler Relat Disord 22:153–156

    Article  Google Scholar 

Download references

Funding

This research received grant from deputy of research of Tehran University of Medical Science.

Author information

Authors and Affiliations

  1. Department of Oral & Maxillofacial Medicine, School of Dentistry, Tehran University of Medical Science, Tehran, Iran

    Narges Gholizadeh, Fatemeh Tavakol & Nafiseh Sheykhbahaei

  2. Iran National Tumor Bank, Cancer Biology Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran

    Amirnader Emami Razavi

  3. Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran

    Hadiseh Mohammadpour

Authors
  1. Narges Gholizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amirnader Emami Razavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hadiseh Mohammadpour
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fatemeh Tavakol
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nafiseh Sheykhbahaei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nafiseh Sheykhbahaei.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gholizadeh, N., Emami Razavi, A., Mohammadpour, H. et al. Association of MAPK and its regulatory miRNAs (603, 4301, 8485, and 4731) with the malignant transformation of oral lichen planus. Mol Biol Rep 47, 1223–1232 (2020). https://doi.org/10.1007/s11033-019-05223-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-019-05223-6

Keywords

Search

Navigation